Group items tagged

In this report, the global catheter stabilization device market is segmented based on product, application, end user and geography. Based on products the market is segmented into arterial securement devices, central venous catheter securement device, peripheral securement devices, abdominal drainage tubes securement devices, epidural securement devices, chest drainage tube securement devices, and all-site devices. Based on applications the market is segmented into general surgery, cardiovascular, respiratory, urological, gastric and oropharyngeal, radiology and other applications. The end users for this market are hospitals, emergency clinics, home healthcare providers, and diagnostic centers. Based on geography the global catheter stabilization device market is segmented into North America, Europe, Asia and Rest of the World (RoW).

In this report, the global catheter stabilization device market is segmented based on product, application, end user and geography. Based on products the market is segmented into arterial securement devices, central venous catheter securement device, peripheral securement devices, abdominal drainage tubes securement devices, epidural securement devices, chest drainage tube securement devices, and all-site devices. Based on applications the market is segmented into general surgery, cardiovascular, respiratory, urological, gastric and oropharyngeal, radiology and other applications. The end users for this market are hospitals, emergency clinics, home healthcare providers, and diagnostic centers. Based on geography the global catheter stabilization device market is segmented into North America, Europe, Asia and Rest of the World (RoW).

The global air monitoring equipment market by product, end user, component, technology and geography. The end user segments included in this report are government and academia, commercial and residential users, refining, and oil and gas industries, power plants, pharmaceutical industry, and other end users (chemical, food, metal, and mining industries). The product segments included in this report are indoor air quality monitors and outdoor air quality monitors. Each of these market segments is further divided into multiple product segments and subsegments. The indoor air quality monitors are categorized into indoor fixed monitors and indoor portable monitors. Similarly, the outdoor air quality monitors are categorized into AQM stations, dust & particulate monitors, outdoor fixed monitors, and outdoor portable monitors.

[313 pages] The Asia-Pacific Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market have been segmented according to the type of isotope, and applications. Both these markets are broken down into segments and sub-segments, providing exhaustive value analysis for the years 2010, 2011, 2012, and forecast to 2017.

Market Overview: Next-generation antibody therapeutics includes the use of new improvised therapeutic antibody to form innovative medicines for treating various diseases. Next-generation antibody therapeutics is developed clinically by pharmaceutical and biotechnology companies for several diseases. The Next Generation Antibody Therapeutics Market size was worth $ XX million in 2018 and is forecasted to reach $ XX million by 2026, expected to grow at a high CAGR during the forecast period 2019-2026. Market Dynamics: The Next Generation Antibody Therapeutics Market is growing due to several factors such as rising incidence of chronic diseases, increasing emergence of antibody technology, new drug discovery, large number of government initiatives, and growing research and development activities for new therapies. Rising prevalence of chronic disease such as cancer, asthma, diabetes and COPD are boosting the growth of the next generation antibody therapeutics market. For instance, according to National Cancer Institute in 2018, in United States, an estimated 1,735,350 new cases of cancer will be diagnosed and 609,640 people will die from the disease. The development of next-generation monoclonal antibodies has expanded beyond oncology into all therapeutic areas. For instance, ADCs were initially focused primarily on cancer, but Genentech has applied to infectious diseases, leading to the discovery and development of THIOMAB antibiotic conjugates (TACs) for the treatment of methicillin-resistant Staphylococcus aureus (MRSA). The technological advancements in antibody therapeutics have led to the development of more efficient antibody therapeutics, hence, driving the growth in the next-generation antibody therapeutics market. However, stringent government regulation, high cost and time required for research and development activities are some of the factors hindering the growth for global next-generation antibody therapeutics market. Market Segmentation: Based o

The global digital X-ray market is estimated to be worth $4.82 billion by 2018, growing at a CAGR of 4.5% from 2013 to 2018. The digital X-ray market is divided into three segments based on types, major products and applications in imaging. Based on types, the market is segmented into computed radiography and digital radiography; the latter is the fastest-growing market.

This research report categorizes and analyzes the global next generation sequencing market on the basis of steps in the NGS workflow and applications. These markets are further divided into segments and sub-segments, to provide exhaustive value analysis for the years 2012, 2013, and 2014 forecast to 2020. Each market is comprehensively analyzed at a granular level by geography (North America, Europe, Asia, and Rest of the World) to provide in-depth information on the global scenario.

The report extensively covers the healthcare provider IT and payer IT markets. The market in this report has been segmented on the basis of its applications, delivery modes, and components. Based on applications, the healthcare information technology is segmented into provider (clinical information technology and non-clinical information technology) and payer, while the market by delivery mode is further categorized as on-premises, web-based, and cloud-based.

The antibody production market is segmented on the basis of products, types, technologies, applications, and end users. The increasing demand for monoclonal antibodies globally and rising R&D expenditure of pharmaceutical and biotechnology companies are major factors driving this market. Moreover, emerging markets of India and China, rising demand for protein therapeutics, and increasing risk of pandemics and infectious diseases are likely to increase the demand for equipment and consumables used in antibody production. However, high cost of primary antibodies is likely to restrain the growth of this market

The antibody production market is segmented on the basis of products, types, technologies, applications, and end users. The increasing demand for monoclonal antibodies globally and rising R&D expenditure of pharmaceutical and biotechnology companies are major factors driving this market. Moreover, emerging markets of India and China, rising demand for protein therapeutics, and increasing risk of pandemics and infectious diseases are likely to increase the demand for equipment and consumables used in antibody production. However, high cost of primary antibodies is likely to restrain the growth of this market

The aesthetic implants segment is classified into breast implants (silicone breast implants, saline breast implants, and cohesive semi-solid gel implants), and other implants (aesthetic dental implants, and soft tissue implants). The facial aesthetics segment is also categorized botulinum toxin (BOTOX), chemical peels, microdermabrasion, and dermal fillers (absorbable dermal fillers, and non-absorbable dermal fillers).

Market Overview: Skin substitutes are natural, synthetic or biosynthetic materials, used to cover large wounds to restore at least some of the functions of the skin. Skin substitutes provides temporary or permanent wound closure and protect the wound from infection, further damage and water loss, and reduce pain. They also facilitate the growth of the normal skin over the wound. Skin substitutes provide a permanent solution and are used in the treatment of conditions like burns, trauma wounds, diabetes or venous ulcers, where skin grafts may not be possible. Market Dynamics: Rising chronic skin diseases is expected to drive the skin substitutes market. For instance, according to the global burden of disease study 2013, Skin conditions contributed around 1.79% to the global disease burden. According to the World Health Organization, about 132,000 melanoma skin cancers occur each year worldwide. Thus, the rising chronic diseases is increasing the demand for skin substitutes in the forecast period. Rising prevalence of diabetes is expected to boost the market. This is owing to the risk of developing a diabetic foot ulcer over the period of time in diabetic patients. For instance, WHO has reported that the incidence of diabetes for all age-groups worldwide was estimated to be 2.8% in 2000 and 4.4% in 2030. The total number of people with diabetes is anticipated to rise from 171 million in 2000 to 366 million in 2030. Thus, as a consequence, the prevalence of diabetes related complications are expected to increase over the forecast period. There are several limitations to the commercially available skin substitutes, like reduced vascularization, poor mechanical integrity, failure to integrate, scarring, and immune rejection. Market Segmentation: Rise in preference for acellular skin substitutes to implant-based skin surgery is expected to drive the growth of the skin substitutes market. For instance, the American Society of Plastic Surgeons in 2012, reported that

[No of pages - 280 ] Browse 120 market tables and 29 figures/charts on North American Nuclear Medicine / Radiopharmaceuticals Market report segmented the North American market By Applications (Deuterium, C-13), (Cancer/Oncology, Cardiac) By Stable Isotopes, SPECT/PET Radioisotopes (Technetium, F-18) & by Geography - Forecasting -2017

[140 Slides Report] Digital X-Ray Market Report categorizes the Global Market by Types (Digital Radiography, Computational Radiography), Applications (Chest Imaging, Mammography, Dental), Product Segments (Flat Panel Detectors, Software, X-Ray Contrast Media, CMOS, CCD), & by Geography

Digital X-Ray Market Report categorizes the Global Market by Types (Digital Radiography, Computational Radiography), Applications (Chest Imaging, Mammography, Dental), Product Segments (Flat Panel Detectors, Software, X-Ray Contrast Media, CMOS, CCD), & by Geography

Laboratory automation market has great segmentation, which is based on the equipment and software programs used, applications of these techniques and geographical demands on the global platform.

European Nuclear Medicine / Radiopharmaceuticals Market report segmented the Europe market By Stable Isotopes (Deuterium, C-13), Applications (Cancer/Oncology, Cardiac) [SPECT/PET ] & by Geography

North American Nuclear Medicine / Radiopharmaceuticals Market report segmented the North American market By Applications (Deuterium, C-13), (Cancer/Oncology, Cardiac) By Stable Isotopes, SPECT/PET Radioisotopes (Technetium, F-18) & by Geography - Forecasting -2017

[Price: $4650] [No of pages - 280 ] Browse 120 market tables and 29 figures/charts on North American Nuclear Medicine / Radiopharmaceuticals Market report segmented the North American market By Applications (Deuterium, C-13), (Cancer/Oncology, Cardiac) By Stable Isotopes, SPECT/PET Radioisotopes (Technetium, F-18) & by Geography - Forecasting -2017

[Price: $4650] [No of pages - 346 ] Browse 142 market tables and 44 figures/charts on Nuclear Medicine / Radiopharmaceuticals Market report segmented the global market by Applications (Cancer/Oncology, Cardiac), By Stable Isotopes (Deuterium, C-13),[SPECT/PET Radioisotopes (Technetium, F-18)] & by Geography - Forecasting - 2017

[Price: $4650] [No of slides - 130] Browse 9 tables and 26 figures/charts on Transfection Market analysis & categorizes (Gene, DNA, Protein, SiRNA, Cell Transfection) the market size and global revenue has been forecasted based on four segmentation: technology, products, applications and by geography.

[Price: $4650] [No of pages - 346 ] Browse 142 market tables and 44 figures/charts on Nuclear Medicine / Radiopharmaceuticals Market report segmented the global market by Applications (Cancer/Oncology, Cardiac), By Stable Isotopes (Deuterium, C-13),[SPECT/PET Radioisotopes (Technetium, F-18)] & by Geography - Forecasting - 2017